Jefferies Adjusts Price Target#
Jefferies has lowered its price target for Procter & Gamble (NYSE: PG) from $179 to $175, while still keeping a Buy rating on the stock. This adjustment comes as the company faces a more challenging environment in the second half of the fiscal year.
Earnings Outlook#
The analysts at Jefferies noted that while Procter & Gamble is expected to meet consensus expectations for the third fiscal quarter, the outlook for earnings per share (EPS) has been revised downwards. They reduced their EPS estimates for fiscal years 2026 and 2027 by 1% and 4%, respectively. This change reflects ongoing uncertainties regarding the duration of higher input costs, which are expenses incurred in producing goods.
Upcoming Earnings Report#
Procter & Gamble is set to release its fiscal third-quarter earnings report on April 24, just four days away. Analysts from UBS have also maintained a Buy rating, predicting an EPS of $1.56, which aligns with consensus estimates from other financial platforms. Additionally, the company has warned shareholders against an unsolicited offer from Potemkin Limited to buy shares at $100 each, significantly below the current market value.
Market Dynamics#
In the broader market context, other analysts have also adjusted their price targets for Procter & Gamble. Piper Sandler has reduced its target from $150 to $142, citing concerns over rising costs linked to oil derivatives. Meanwhile, Evercore ISI has maintained an In Line rating with a target of $170, noting the impact of ongoing commodity pressures on the company’s profit margins. These adjustments highlight the various financial challenges currently affecting Procter & Gamble.